Gouma S, Weirick M, Hensley SE. Antigenic assessment of the H3N2 component of the 2019-2020 Northern Hemisphere influenza vaccine. Nat Commun. 2020 May 15;11(1):2445
The 2019-2020 Northern Hemisphere influenza vaccine includes antigens from 3c3.A H3N2 viruses; however, over half of circulating H3N2 viruses belong to subclade 3c2.A1b. Here, we analyze antibody responses elicited by the egg-adapted 3c3.A H3N2 vaccine strain in ferrets and humans. We find that this vaccine strain elicits antibodies that have reduced reactivity to a wild-type 3c3.A strain and very limited reactivity to 3c2.A strains, including the currently circulating 3c2.A1b strain.
See Also:
Latest articles in those days:
- Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations-United States, September 1, 2023-May 31, 2024 19 hours ago
- Viral Mastitis Associated with Influenza A in Dairy Cattle 19 hours ago
- Global Prevalence and Distribution of H9 Subtype of Avian Influenza Viruses in Wild Birds: Literature Review with Meta-Analysis 19 hours ago
- A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses 2 days ago
- Thermal inactivation spectrum of influenza A H5N1 virus in raw milk 2 days ago
[Go Top] [Close Window]